论文部分内容阅读
81例白血病和淋巴瘤患者血清铜氧化酶的活性被检测,结果显示急性白血病,慢性白血病及恶性淋巴瘤患者血清铜氧化酶活性均高于正常(P<0.05～0.001);急性白血病患者,急非淋与急淋之间无统计学差异(P>0.05),提示血清铜氧化酶活性的改变,对急性白血病类型无判别意义;急性白血病患者初治和复发患者治疗前明显高于正常,而经治疗缓解后下降,提示血清铜氧化酶活性的改变对于观察急性白血病的疗效有一定的临床意义。
81 cases of leukemia and lymphoma serum copper oxidase activity was detected, the results showed that acute leukemia, chronic leukemia and malignant lymphoma serum copper oxidase activity were higher than normal (P <0.05 ~ 0.001); acute leukemia patients, acute (P> 0.05), suggesting that changes in serum copper oxidase activity, acute leukemia type no discriminant significance; acute leukemia in patients with initial treatment and relapse was significantly higher than normal before treatment, and Decreased after treatment, suggesting that changes in serum copper oxidase activity for the observation of the efficacy of acute leukemia has some clinical significance.